158 related articles for article (PubMed ID: 28859028)
1. Sinusoidal Obstruction Syndrome During Chemotherapy of Pediatric Cancers and its Successful Management With Defibrotide.
Kizilocak H; Dikme G; Özdemir N; Kuruğoğlu S; Adaletli İ; Erkan T; Celkan T
J Pediatr Hematol Oncol; 2017 Oct; 39(7):e373-e376. PubMed ID: 28859028
[TBL] [Abstract][Full Text] [Related]
2. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ
Br J Haematol; 2017 Jul; 178(1):112-118. PubMed ID: 28444784
[TBL] [Abstract][Full Text] [Related]
3. Defibrotide for the management of sinusoidal obstruction syndrome in patients who undergo haemopoietic stem cell transplantation.
Coutsouvelis J; Avery S; Dooley M; Kirkpatrick C; Spencer A
Cancer Treat Rev; 2016 Nov; 50():200-204. PubMed ID: 27721142
[TBL] [Abstract][Full Text] [Related]
4. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
5. Defibrotide sodium for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Richardson PG; Triplett BM; Ho VT; Chao N; Dignan FL; Maglio M; Mohty M
Expert Rev Clin Pharmacol; 2018 Feb; 11(2):113-124. PubMed ID: 29301447
[TBL] [Abstract][Full Text] [Related]
6. The Role of Thromboelastography in Pediatric Patients with Sinusoidal Obstructive Syndrome Receiving Defibrotide.
Gendreau JL; Knoll C; Adams RH; Su LL
Biol Blood Marrow Transplant; 2017 Apr; 23(4):707-712. PubMed ID: 28115278
[TBL] [Abstract][Full Text] [Related]
7. Hepatic veno-occlusive disease during chemotherapy for nephroblastoma: successful and safe treatment with defibrotide. Report of a clinical case.
Cecinati V; Giordano P; De Leonardis F; Grassi M; Arcamone G; De Mattia D; Santoro N
Immunopharmacol Immunotoxicol; 2009; 31(4):702-5. PubMed ID: 19874245
[TBL] [Abstract][Full Text] [Related]
8. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Richardson PG; Smith AR; Triplett BM; Kernan NA; Grupp SA; Antin JH; Lehmann L; Shore T; Iacobelli M; Miloslavsky M; Hume R; Hannah AL; Nejadnik B; Soiffer RJ;
Biol Blood Marrow Transplant; 2017 Jun; 23(6):997-1004. PubMed ID: 28285079
[TBL] [Abstract][Full Text] [Related]
9. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
Corbacioglu S; Richardson PG
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
[TBL] [Abstract][Full Text] [Related]
10. Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with Defibrotide.
Choi A; Kang YK; Lim S; Kim DH; Lim JS; Lee JA
Cancer Res Treat; 2016 Oct; 48(4):1443-1447. PubMed ID: 27034141
[TBL] [Abstract][Full Text] [Related]
11. Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: report of a case and review of the literature.
Kotecha RS; Buckland A; Phillips MB; Cole CH; Gottardo NG
J Pediatr Hematol Oncol; 2014 Jan; 36(1):76-80. PubMed ID: 24276042
[TBL] [Abstract][Full Text] [Related]
12. Treatment of sinusoidal obstruction syndrome with defibrotide: a single-center experience.
Sucak GT; Aki ZS; Yagcí M; Yegin ZA; Ozkurt ZN; Haznedar R
Transplant Proc; 2007 Jun; 39(5):1558-63. PubMed ID: 17580188
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment with defibrotide for sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.
Yakushijin K; Matsui T; Okamura A; Yamamoto K; Ito M; Chihara K
Kobe J Med Sci; 2005; 51(3-4):55-65. PubMed ID: 16444097
[TBL] [Abstract][Full Text] [Related]
14. Education and imaging. Hepatobiliary and pancreatic: sinusoidal obstruction syndrome during chemotherapy.
Menke J
J Gastroenterol Hepatol; 2011 Jun; 26(6):1083. PubMed ID: 21564291
[No Abstract] [Full Text] [Related]
15. Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide.
Saviola A; Luppi M; Potenza L; Morselli M; Ferrari A; Riva G; Torelli G
Br J Haematol; 2003 Nov; 123(4):752-3. PubMed ID: 14616990
[No Abstract] [Full Text] [Related]
16. Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation.
Park M; Park HJ; Eom HS; Kwon YJ; Park JA; Lim YJ; Yoon JH; Kong SY; Ghim TT; Lee HW; Yun T; Park BK
Ann Transplant; 2013 Jan; 18():36-42. PubMed ID: 23792499
[TBL] [Abstract][Full Text] [Related]
17. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
[TBL] [Abstract][Full Text] [Related]
18. Veno-occlusive disease in pediatric patients affected by Wilms tumor.
Cesaro S; Spiller M; Sartori MT; Alaggio R; Peruzzo M; Saggiorato G; Bisogno G
Pediatr Blood Cancer; 2011 Aug; 57(2):258-61. PubMed ID: 21246705
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin treatment of severe hepatic veno-occlusive disease in children with cancer.
Mertens R; Brost H; Granzen B; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S154-8. PubMed ID: 10650858
[TBL] [Abstract][Full Text] [Related]
20. Defibrotide: An Oligonucleotide for Sinusoidal Obstruction Syndrome.
Aziz MT; Kakadiya PP; Kush SM; Weigel K; Lowe DK
Ann Pharmacother; 2018 Feb; 52(2):166-174. PubMed ID: 28914546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]